PP_1170x120_10-25-21

James  Kiley

NIH clinical trial to evaluate the safety and effectiveness of hydroxychloroquine begins

NIH clinical trial to evaluate the safety and effectiveness of hydroxychloroquine begins

NEW YORK — A clinical trial to evaluate the safety and effectiveness of hydroxychloroquine for the treatment of adults hospitalized with coronavirus disease 2019 (COVID-19) has begun, with the first participants now enrolled in Tennessee. The Outcomes Related to COVID-19 treated with hydroxychloroquine among In-patients with symptomatic Disease study, or ORCHID Study, is being conducted